Table 1.
Baseline characteristics of patients enrolled into the CLOTS 1 trial
Thigh-length GCS (n=1256) | Avoid GCS (n=1262) | |
---|---|---|
Overall | ||
Age (years)* | 76 (68–83) | 76 (68–83) |
Men | 620 (49·4%) | 622 (49·3%) |
Final diagnosis at hospital discharge | ||
Ischaemic stroke | 1058 (84·2%) | 1087 (86·1%) |
Haemorrhagic stroke | 132 (10·5%) | 100 (7·9%) |
Uncertain | 39 (3·1%) | 38 (3·0%) |
Non-strokes (included in primary analysis) | 24 (1·9%) | 35 (2·8%) |
Missing (no discharge form) | 3 (0·2%) | 2 (0·2%) |
Past history and risk factors | ||
Previous DVT or PE | 55 (4·4%) | 56 (4·4%) |
Diabetes | 191 (15·2%) | 165 (13·1%) |
Peripheral vascular disease | 36 (2·9%) | 26 (2·1%) |
Overweight | 320 (25·5%) | 343 (27·2%) |
Cigarette smoker | 235 (18·7%) | 235 (18·6%) |
Independent in daily activities before stroke* | 1145 (91·2%) | 1152 (91·3%) |
Lives alone before stroke* | 443 (35·3%) | 461 (36·5%) |
Indicators of stroke severity | ||
Able to lift both arms off bed* | 547 (43·5%) | 558 (44·2%) |
Able to talk and oriented in time, place, and person* | 898 (71·5%) | 890 (70·5%) |
Able to lift both legs off bed† | 542 (43·1%) | 550 (43·6%) |
Able to walk without help* | 0 (0%) | 0 (0%) |
Prescribed heparin, warfarin, or alteplase at baseline† | 98 (7·8%) | 109 (8·6%) |
Delay since stroke onset to randomisation (0–1days)† | 525 (41·8%) | 511 (40·5%) |
Stroke severity: probability of being alive and independent in daily activities 0–0·15† | 660 (52·5%) | 684 (54·2%) |
Stroke severity: probability of being alive and independent in daily activities | 0·14 (0·04–0·38) | 0·12 (0·03–0·40) |
Compression Doppler ultrasound at 30 days considered unlikely to be practical at time of randomisation | 351 (27·9%) | 330 (26·1%) |
Data are median (IQR) or number (%). GCS=graduated compression stockings. DVT=deep vein thrombosis. PE=pulmonary embolism.
Factors included in model to predict probability of being alive and independent at 6 months.20
Variables included in minimisation.